BeStock  
Stocks › Biotechnology › ATTO

Attovia Therapeutics ATTO

US equityMarket cap rank #3483Biotechnology
$15.72 −$0.70 (-4.26%)
Market open · Oct 8, 12:30 pm ET · After hours $16.42 0.00%
Open$16.27
Prev close$16.42
Day range$15.48 – $16.38
Volume143.3K
Market cap$717.64M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$450,000.00
Operating profit-$21.80M-31.2% YoY
Net profit-$20.69M-43.3% YoY
Diluted EPS-$0.48+14.5% YoY
Free cash flow-$16.86M-33.2% YoY
Operating cash flow-$16.79M

Revenue, last 8 quarters

$327.3MDec '21$356.6MMar '22$363.8MJun '22$346.8MSep '22$0.0Mar '25$0.0Jun '25$0.0Mar '26$450.0KJun '26

Net profit, last 8 quarters

$-46.3MDec '21$-70.6MMar '22$-12.1MJun '22$1.5MSep '22$-15.2MMar '25$-14.4MJun '25$-18.7MMar '26$-20.7MJun '26

Diluted EPS by quarter

-3.09Dec '21-4.99Mar '22-0.83Jun '220.10Sep '22-0.60Mar '25-0.56Jun '25-0.73Mar '26-0.48Jun '26

Free cash flow by quarter

$-12.9MDec '21$-44.8MMar '22$18.9MJun '22$-12.4MSep '22$-15.9MMar '25$-12.7MJun '25$-18.4MMar '26$-16.9MJun '26

Annual revenue

$1.8BFY18$1.7BFY19$1.4BFY20$1.4BFY21$0.0FY24$1.4MFY25

Profitability & balance sheet

Operating margin-4,232.9%
Net margin-3,910.0%
Return on assets-54.8%
Current ratio9.39
Liabilities / assets213.3%
Cash & investments$115.13M
Total debt$2.29M
Net cash (debt)$112.84M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Total Revenue as Reported $450,000.00 – $1.35M $0.00 –
Total Operating Revenue $450,000.00 $0.00 $1.35M $0.00 $0.00
Operating Expense $22.25M $19.96M $68.51M $16.62M $16.10M
Selling and Admin Expenses $3.31M $3.21M $14.36M $3.03M $4.25M
-General & Admin Expense $3.31M $3.21M $14.36M $3.03M $4.25M
Research & Development $18.95M $16.75M $54.15M $13.59M $11.86M
Operating Profit -$21.80M -$19.96M -$67.16M -$16.62M -$16.10M
Net Non-Operating Interest Income (Expense) $1.14M $1.33M $6.63M $2.04M $1.13M
Non-Operating Interest Income $1.14M $1.33M $6.63M $2.04M $1.13M
Other Income (Expense) -$25,000.00 -$27,000.00 -$95,000.00 $140,000.00 -$173,000.00
Other Non-Operating Income (Expenses) -$25,000.00 -$27,000.00 -$95,000.00 $140,000.00 -$173,000.00
Pretax Profit -$20.69M -$18.66M -$60.63M -$14.44M -$15.15M
Net Profit -$20.69M -$18.66M -$60.63M -$14.44M -$15.15M
Profit from Continuing Operations -$20.69M -$18.66M -$60.63M -$14.44M -$15.15M
Net Income to Parent Company -$20.69M -$18.66M -$60.63M -$14.44M -$15.15M
Other Preferred Stock Dividends $0.00 $0.00 $271,000.00 $0.00 $271,000.00
Net Income to Common Stockholders -$20.69M -$18.66M -$60.90M -$14.44M -$15.42M
Basic EPS -$0.48 -$0.73 -$2.37 -$0.56 -$0.60
Diluted EPS -$0.48 -$0.73 -$2.37 -$0.56 -$0.60

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2024 ANNUAL 2022 Q3
Total Assets $128.35M $146.09M $165.89M $76.72M $992.46M
Total Current Assets $118.40M $136.64M $156.30M $72.48M $458.61M
Cash and Cash Equivalents & Short-Term Investments $115.13M $132.62M $152.27M $69.32M $67.76M
-Cash and Cash Equivalents $32.83M $43.30M $40.19M $30.63M $66.31M
-Short Term Investments $82.30M $89.33M $112.08M $38.69M $1.45M
Other Current Assets $3.27M $4.02M $4.03M $3.16M –
Total Non-Current Assets $9.95M $9.44M $9.60M $4.23M $533.85M
Net PPE $6.92M $7.49M $7.87M $3.23M $187.17M
-Gross PPE $8.51M $8.83M $8.96M $3.53M $187.17M
-Accumulated Depreciation -$1.59M -$1.34M -$1.10M -$295,000.00 –
Other Non-Current Assets $3.03M $1.95M $1.73M $1.00M $22.46M
Total Liabilities $273.81M $271.60M $273.33M $123.54M $1.16B
Total Current Liabilities $12.62M $9.80M $11.01M $7.72M $485.24M
Payables $6.00M $2.56M $3.55M $4.14M $291.60M
-Accounts Payable $6.00M $2.56M $3.55M $4.14M $83.81M
Current Accrued Expenses $2.67M $3.52M $1.98M $1.52M –
Short-Term Debt and Capital Lease Obligation $2.04M $1.98M $1.92M – $138.03M
-Current Capital Lease Obligation $2.04M $1.98M $1.92M $0.00 $43.79M
Current Deferred Liabilities $0.00 $450,000.00 $450,000.00 $0.00 –
Total Non-Current Liabilities $261.19M $261.80M $262.32M $115.82M $671.30M
Long Term Debt and Capital Lease Obligation $2.29M $2.83M $3.34M $0.00 $577.53M
-Long Term Capital Lease Obligation $2.29M $2.83M $3.34M $0.00 $87.95M
Convertible preferred securities $258.23M $258.23M $258.23M $115.59M –
Other Non-Current Liabilities $678,000.00 $750,000.00 $755,000.00 $228,000.00 -$2,000.00
Total Equity -$145.46M -$125.52M -$107.44M -$46.83M -$164.08M
Stockholders' Equity -$145.46M -$125.52M -$107.44M -$46.83M -$164.08M
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $50,000.00
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00 $50,000.00
Additional Paid-In Capital $4.97M $4.18M $3.47M $3.49M $618.51M
Retained Earnings -$150.35M -$129.67M -$111.01M -$50.38M -$354.97M
Gains/Losses Not Affecting Retained Earnings -$79,000.00 -$27,000.00 $99,000.00 $67,000.00 -$433.63M
Receivables – – – – $381.30M
-Accounts Receivable – – – – $157.18M
-Taxes Receivable – – – – $68.61M
-Other Receivables – – – – $155.52M
Prepaid Assets – – – – $9.55M
Investments and Advances – – – – $32.95M
-Available for Sale Securities – – – – $32.95M
Financial Assets – – – – $0.00
Non Current Accounts Receivables – – – – $4.80M
Non-Current Prepaid Assets – – – – $3.41M
Goodwill and Other Intangible Assets – – – – $171.67M
-Goodwill – – – – $91.38M
-Other Intangible Assets – – – – $80.29M
Non-Current Deferred Assets – – – – $111.39M
-Total Tax Payable – – – – $96.12M
-Other Payable – – – – $111.67M
-Current Debt – – – – $94.24M
Current Provisions – – – – $10.23M
Other Current Liabilities – – – – $45.38M
Long Term Accounts Payable and Other Payables – – – – $8.03M
-Long Term Debt – – – – $489.58M
Derivative Product Liabilities – – – – $46.37M
Non-Current Liabilities – – – – $39.38M
Less: Treasury Stock – – – – $12.69M
Other Equity Interests – – – – $18.66M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Operating Cash Flow -$16.79M -$18.14M -$59.20M -$12.57M -$14.13M
Net cash flow from continuing operations -$16.79M -$18.14M -$59.20M -$12.57M -$14.13M
Net Income from Continuing Operations -$20.69M -$18.66M -$60.63M -$14.44M -$15.15M
Depreciation & Depletion & Amortization $246,000.00 $242,000.00 $804,000.00 $207,000.00 $143,000.00
Other Non-Cash Items $402,000.00 $393,000.00 $48,000.00 $379,000.00 $253,000.00
Change in Working Capital $2.64M -$541,000.00 $276,000.00 $1.53M $28,000.00
-Change in Prepaid Assets $850,000.00 $122,000.00 -$420,000.00 -$143,000.00 $1.25M
-Change in Payables and Accrued Expense $2.25M -$216,000.00 $1.30M $1.86M -$1.02M
-Change in Other Current Assets $14,000.00 $11,000.00 -$98,000.00 -$29,000.00 -$186,000.00
-Change in Other Current Liabilities -$478,000.00 -$458,000.00 -$509,000.00 -$163,000.00 -$12,000.00
Net cash flow from investing $6.88M $22.49M -$73.46M -$74.17M -$29.29M
Net Cash Flow from Continuing Investing Activities $6.88M $22.49M -$73.46M -$74.17M -$29.29M
Net PPE Purchase and Sale -$73,000.00 -$288,000.00 -$2.31M -$94,000.00 -$1.79M
Net Investment Purchase and Sale $6.95M $22.77M -$71.14M -$74.07M -$27.50M
Financing Cash Flow -$556,000.00 -$1.24M $142.01M $72,000.00 $141.89M
Net Cash Flow from Continuing Financing Activities -$556,000.00 -$1.24M $142.01M $72,000.00 $141.89M
Net Common Stock Issuance $31,000.00 $11,000.00 $194,000.00 $98,000.00 $45,000.00
Net Preferred Stock Issuance $0.00 $0.00 $142.19M $0.00 $142.19M
Net Other Financing Charges -$587,000.00 -$1.25M -$376,000.00 -$26,000.00 -$345,000.00
Ending Cash Balance $33.23M $43.70M $40.60M $43.05M $129.71M
Net Change in Cash -$10.47M $3.10M $9.36M -$86.66M $98.47M
Beginning Cash Balance $43.70M $40.60M $31.24M $129.71M $31.24M
Free Cash Flow -$16.86M -$18.43M -$61.51M -$12.66M -$15.92M
Gain/Loss from Continuing Operations – – $7,000.00 $0.00 $6,000.00
Net Issuance Payments Of Debt – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on ATTO.

Leave a comment

Scroll to Top